18F-labelled BBN analogues AMBA and RMI (DOTA-CH2CO-G-4-aminobenzoyl-f-W-A-V-G-H-Sta-L-NH2, GRPR antagonist) were first synthesized for molecular PET imaging of PCa in 2013 [2]. The gene discussed is GRPR; the disease is posterior cortical atrophy.